GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (LTS:0RK9) » Definitions » Cyclically Adjusted FCF per Share

Alligator Bioscience AB (LTS:0RK9) Cyclically Adjusted FCF per Share : kr-891.49 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Alligator Bioscience AB's adjusted free cash flow per share for the three months ended in Mar. 2025 was kr-7,282.500. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-891.49 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-05-28), Alligator Bioscience AB's current stock price is kr3.918. Alligator Bioscience AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr-891.49. Alligator Bioscience AB's Cyclically Adjusted Price-to-FCF of today is .


Alligator Bioscience AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Alligator Bioscience AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Cyclically Adjusted FCF per Share Chart

Alligator Bioscience AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alligator Bioscience AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -891.49

Competitive Comparison of Alligator Bioscience AB's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Alligator Bioscience AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alligator Bioscience AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Alligator Bioscience AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alligator Bioscience AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-7282.5/132.8245*132.8245
=-7,282.500

Current CPI (Mar. 2025) = 132.8245.

Alligator Bioscience AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 100.225 0.000
201509 174.938 100.228 231.832
201512 -18.637 100.276 -24.686
201603 -13.700 100.751 -18.061
201606 8.918 101.019 11.726
201609 -11.511 101.138 -15.117
201612 -10.487 102.022 -13.653
201703 -15.253 102.022 -19.858
201706 -14.313 102.752 -18.502
201709 -16.021 103.279 -20.604
201712 -26.289 103.793 -33.642
201803 0.487 103.962 0.622
201806 -19.591 104.875 -24.812
201809 -25.032 105.679 -31.462
201812 -26.343 105.912 -33.037
201903 -19.807 105.886 -24.846
201906 -27.446 106.742 -34.153
201909 -35.212 107.214 -43.623
201912 -32.233 107.766 -39.728
202003 -30.889 106.563 -38.501
202006 -20.815 107.498 -25.719
202009 -20.404 107.635 -25.179
202012 -31.332 108.296 -38.429
202103 -21.419 108.360 -26.255
202106 -20.137 108.928 -24.555
202109 -16.864 110.338 -20.301
202112 -16.921 112.486 -19.980
202203 -10.382 114.825 -12.009
202206 -15.937 118.384 -17.881
202209 -16.383 122.296 -17.793
202212 -18.192 126.365 -19.122
202303 -19.051 127.042 -19.918
202306 -10.280 129.407 -10.552
202309 -6.229 130.224 -6.353
202312 -7.003 131.912 -7.051
202403 -10.639 132.205 -10.689
202406 -4.355 132.716 -4.359
202409 -6.437 132.304 -6.462
202412 -3.762 132.987 -3.757
202503 -7,282.500 132.825 -7,282.500

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Alligator Bioscience AB  (LTS:0RK9) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Alligator Bioscience AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Alligator Bioscience AB Business Description

Industry
Traded in Other Exchanges
Address
Medicon Village, Scheeletorget 1, Lund, SWE, 223 81
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.

Alligator Bioscience AB Headlines

No Headlines